Evidence map›Paper›PMID 40961865›Full record

ArticleCryobiology2025

High-throughput evaluation of cryoprotective agents for mixture effects that reduce toxicity.

Nima Ahmadkhani, Cameron Sugden, James D Benson, Ali Eroglu, Adam Z Higgins

Abstract read
In one paragraph

Article in Cryobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Thermodynamic Principles of Emerging Cryopreservation Technologies.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nima AhmadkhaniSchool of Chemical, Biological and Environmental Engineering, Oregon State University, US.
Cameron SugdenSchool of Chemical, Biological and Environmental Engineering, Oregon State University, US.
James D BensonDepartment of Biology, University of Saskatchewan, Canada.
Ali ErogluDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia - Augusta University, US.
Adam Z HigginsSchool of Chemical, Biological and Environmental Engineering, Oregon State University, US. Electronic address: Adam.Higgins@oregonstate.edu.

Funding

Viable Banking of Human TissuesR01EB027203 · NIBIB · AUGUSTA UNIVERSITY · PI EROGLU, ALI · 2018 to 2021
$1.5M
NIBIB NIH HHS R01 EB027203
6 · The paper itself

Abstract

Vitrification is a promising approach for cryopreserving complex biological structures such as organs. However, to prevent ice formation, high concentrations of cell-permeable cryoprotective agents (CPAs) are required, which can be highly toxic. The current reliance on a small number of CPAs limits optimization of low-toxicity compositions for vitrification. To address this, there is growing interest in uncovering novel chemicals with analogous protective qualities. This may not only enhance vitrification efficacy but also mitigate toxic effects. In the current study, we employed a high throughput method to assess the toxicity of 21 compounds at room temperature, both individually and in binary combinations, using bovine pulmonary artery endothelial cells (BPAEC) as a model system. Our analysis revealed that toxicity increases with both exposure duration and concentration, and that several CPA combinations result in reduced overall toxicity. Notably, among all tested mixtures, four binary combinations-formamide/glycerol, dimethyl sulfoxide/1,3-propanediol, 1,2-propanediol/diethylene glycol, and 1,3-propanediol/diethylene glycol-produced a statistically significant decrease in toxicity, resulting in significantly higher viability for the 6 mol/kg mixture than both corresponding 6 mol/kg single CPA solutions. The high-throughput approach presented here will aid in building a comprehensive CPA toxicity database, which will improve our understanding of toxicity mechanisms and support the development of predictive models for identifying novel CPA mixtures with low toxicity.

Indexed as

CryopreservationCryoprotective AgentsEndothelial CellsAnimalsCattleCells, CulturedCell SurvivalDimethyl SulfoxideGlycerolHigh-Throughput Screening AssaysPulmonary ArteryVitrificationCryoprotective AgentsDimethyl SulfoxideGlycerolAutomated liquid handlingCPACryopreservationCryoprotectantHigh throughputToxicityVitrification

Identifiers

PMID40961865
PMCPMC12536918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.